9 completed. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 9 |
Follow Acute Ischemic Stroke: new trials by email Literature Review of Acute Ischemic Stroke trials Research Report on Acute Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion Tirofiban, Acetylsalicylic acid - Acute Ischemic Stroke | Phase 4 | Completed | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 240 | 2026-03-20 | 2026-04-03 |
| Nicardipine vs. Labetalol nicardipine intravenous, labetalol intravenous - Acute Ischemic Stroke, Hypertensive Crisis | Phase 4 | Completed | Haseki Training and Research Hospital | 34 | 2025-02-01 | 2025-12-11 |
| Comparison of Perioperative Conscious Sedation During Endovascular Thrombectomy in Acute Ischemic Stroke Dexmedetomidine, Midazolam - Acute Ischemic Stroke | Phase 4 | Completed | Jinling Hospital, China | 810 | 2023-11-21 | 2026-09-24 |
| Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window rhTNK-tPA, Antiplatelet Agents - Acute Ischemic Stroke | Phase 4 | Completed | Xuanwu Hospital, Beijing | 570 | 2023-06-02 | 2025-12-02 |
| Effectiveness of Butylphthalide on Dynamic Cerebral Autoregulation in Patients With Acute Ischemic Stroke. butylphthalide(NBP), placebo - Acute Ischemic Stroke | Phase 4 | Completed | Yi Yang | 99 | 2018-02-28 | 2022-06-30 |
| Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke Nerve Growth Factors, normal saline - Acute Ischemic Stroke | Phase 4 | Completed | Jinling Hospital, China | 106 | 2016-01-01 | 2021-08-31 |
| Evaluation Of HUK in Acute Stroke Patients: MRS and CTP Human urinary kallidinogenase (HUK), aspirin® , clopidogrel® , atorvastatin® - Acute Ischemic Stroke | Phase 4 | Completed | Xuanwu Hospital, Beijing | 80 | 2014-01-01 | 2018-02-13 |
| Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke aspirin，chinese herbs； - Acute Ischemic Stroke | Phase 4 | Completed | Guangzhou University of Traditional Chinese Medicine | 314 | 2009-05-01 | 2011-05-17 |
| PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin) Enoxaparin sodium - Acute Ischemic Stroke | Phase 4 | Completed | Sanofi | 2003-08-01 | 2011-01-11 |
Ischemic Stroke (9) · Hereditary Sensory and Autonomic Neuropathies (1) · Hypertensive Crisis (1)
Brain Diseases (9) · Cardiovascular Diseases (9) · Central Nervous System Diseases (9) · Cerebrovascular Disorders (9) · Nervous System Diseases (9) · Stroke (9) · Vascular Diseases (9) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Hypertension (1) · Nervous System Malformations (1) · Neurodegenerative Diseases (1) · Neuromuscular Diseases (1)
Aspirin (3) · Clopidogrel (2) · 3-n-butylphthalide (1) · Atorvastatin (1) · Dexmedetomidine (1) · Midazolam (1) · Nerve Growth Factors (1) · Platelet Aggregation Inhibitors (1) · Saline Solution (1) · Tirofiban (1) · enoxaparin sodium (1)
Jinling Hospital, China (2) · Xuanwu Hospital, Beijing (2) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Guangzhou University of Traditional Chinese Medicine (1) · Haseki Training and Research Hospital (1) · Sanofi (1) · Yi Yang (1)
China (5) · Turkey (Türkiye) (2) · Australia (1) · Austria (1) · Brazil (1) · Canada (1) · Colombia (1) · Czechia (1) · India (1) · Israel (1) · Italy (1) · Mexico (1) · Poland (1) · South Africa (1) · South Korea (1)
Adem Az, Assoc. Prof. (1) · Elena Zapata-Arrizada, PhD (1) · Junwei Hao, MD (1) · Luc Sagnard (1) · Moli Wang, 1 (1) · Qingfeng Ma, MD (1) · Xinfeng Liu (1) · Xinfeng Liu, MD (1) · Yi Yang, MD, PhD (1)
PMID 17448820, PMID 17515473, PMID 19696423, PMID 23055089, PMID 35323883, PMID 36352567, PMID 37021629, PMID 38195586, PMID 40672455, PMID 41642827